BioSpace.com

USA Today -- A new study out this week suggests a dietary supplement from a Chinese plant may create changes on the ends of our chromosomes that help keep DNA intact, possibly boosting the immune system.

WEDNESDAY, Sept. 8 (HealthDay News) -- Statins, lauded for their ability to lower cholesterol and prevent heart attacks and strokes, may also reduce the risk of developing rheumatoid arthritis, Israeli researchers report.

NEW YORK, Sept 8 (Reuters) - The No. 2 research executive at Genentech is leaving for a post in academia -- marking one of the highest-profile departures since the U.S. biotechnology company was acquired by Swiss drugmaker Roche Holding AG (ROG.VX).

ScienceDaily (Sep. 8, 2010) Treating intensive care patients who develop life-threatening bacterial infections, or septicemia, with insulin potentially could reduce their chances of succumbing to the infection, if results of a new preliminary study can be replicated in a larger study.

ScienceDaily (Sep. 8, 2010) An international study has discovered the reason why some people who eat a high-fat diet remain slim, yet others pile on the weight.

Physorg.com -- A team led by a Scripps Research Institute scientist has for the first time identified a new gene that is required for memory formation in Drosophila, the common fruit fly. The gene may have similar functions in humans, shedding light on neurological disorders such as Alzheimer's disease or human learning disabilities.

Script Intelligence -- Shionogi is to slash the number of sales reps it employs in the US by around 50%, in a major restructuring following its 2008 acquisition of Sciele Pharma.

Sep 08, 2010 (NORDIC BUSINESS REPORT via COMTEX) --8 September 2010 - Swedish drug developer Karo Bio AB (STO: KARO) has been notified by its US partner Merck & Co Inc (NYSE: MRK | PowerRating) that it decided to discontinue the development of their joint drug candidate MK-6913 for the treatment of hot flashes.

CHICAGO, Sept 7 (Reuters) - Drugmaker Wyeth used ghostwriters to play up the benefits and downplay the harm of hormone replacement therapy in articles published in medical journals, U.S. researchers said on Tuesday.

SAN DIEGO, Sept. 7 /PRNewswire/ -- Zogenix, Inc. ("Zogenix") announced today that it has filed a registration statement with the Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for...

Bloomberg -- Vertex Pharmaceuticals Inc.s most advanced experimental drug, in development with Johnson & Johnson, worked in patients with hepatitis C who didnt respond to other treatment, a study found.

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX - News) announced that the U.S. Food and Drug Administrations (FDA) Anti-Infective Drugs Advisory Committee voted 21 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 0 in favor of approval for complicated skin and skin structure infections (cSSSI).

SHANGHAI, Sept 8 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd (601607.SS), the Chinese partner of Roche Holding AG (ROG.VX), said on Wednesday it plans to raise at least 8 billion yuan ($1.2 billion) through a public share offering in Hong Kong to fund acquisitions.

Boston Herald -- Lexington-based Cubist Pharmaceuticals is set to expand its campus with the addition of 110,000 square feet of lab space and up to 100 new jobs.

AUSTIN, Texas, Sept. 8 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), today announced that initial results from a study conducted at the NMI Natural and Medical Sciences Institute at the University of Tubingen in Germany demonstrate that its MAGPIX system provides...

Reuters -- Galapagos and GlaxoSmithKline today announced they have reached an agreement forGalapagos to acquire GSK's state-of-the art research centre in Zagreb, Croatia. Thearrangement, which is subject to closing conditions and is expected to be effective asof 9 September 2010, provides for ongoing employment of the staff at the centre and willprovide additional capacity for Galapagos' growing...

MOUNTAIN VIEW, Calif., Sept. 8 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today reported results from a pharmacodynamics (PD) trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate (DHE) administered intravenously (IV) and placebo. In the trial...

Wall Street Journals -- Purdue Pharma LP has agreed to pay $16 million to settle a lawsuit by purchasers of Oxycontin over how it obtained patents on the painkiller in the 1990s, according to a court filing Tuesday.

NEW YORK, Sept 7 (Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.O) has won a ruling in its battle to protect its top-selling multiple sclerosis drug Copaxone from generic rivals.

Sept. 7, 2010 -- Risk for stroke and heart disease falls as education levels rise in high-income countries, but not in nations where earnings are considerably lower, a new study shows.